84 related articles for article (PubMed ID: 6883395)
1. Tumor markers derived from nucleic acid components.
Borek E; Waalkes TP; Gehrke CW
Cancer Detect Prev; 1983; 6(1-2):67-71. PubMed ID: 6883395
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of modified nucleosides in patients with malignant mesothelioma.
Fischbein A; Sharma OK; Selikoff IJ; Borek E
Cancer Res; 1983 Jun; 43(6):2971-4. PubMed ID: 6850607
[TBL] [Abstract][Full Text] [Related]
3. High turnover rate of transfer RNA in tumor tissue.
Borek E; Baliga BS; Gehrke CW; Kuo CW; Belman S; Troll W; Waalkes TP
Cancer Res; 1977 Sep; 37(9):3362-6. PubMed ID: 884680
[TBL] [Abstract][Full Text] [Related]
4. [Studies on nucleic acid metabolism. Molecular biology and clinical significance].
Schöch G
Fortschr Med; 1978 Oct; 96(37):1875-80. PubMed ID: 700570
[TBL] [Abstract][Full Text] [Related]
5. Patterns of urinary excretion of modified nucleosides.
Gehrke CW; Kuo KC; Waalkes TP; Borek E
Cancer Res; 1979 Apr; 39(4):1150-3. PubMed ID: 421198
[TBL] [Abstract][Full Text] [Related]
6. Modified nucleosides in body fluids of tumor-bearing patients.
Salvatore F; Colonna A; Costanzo F; Russo T; Esposito F; Cimino F
Recent Results Cancer Res; 1983; 84():360-77. PubMed ID: 6844698
[TBL] [Abstract][Full Text] [Related]
7. A new family of tumor markers.
Borek E
Cancer Detect Prev; 1981; 4(1-4):185-91. PubMed ID: 7349776
[No Abstract] [Full Text] [Related]
8. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry.
Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ
Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199
[TBL] [Abstract][Full Text] [Related]
9. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
Xu G; Schmid HR; Lu X; Liebich HM; Lu P
Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
[TBL] [Abstract][Full Text] [Related]
10. [Modified nucleosides in tRNA: its structure, biosynthesis and function (author's transl)].
Nishimura S
Tanpakushitsu Kakusan Koso; 1977 Jun; 22 Spec No(7):922-30. PubMed ID: 329357
[No Abstract] [Full Text] [Related]
11. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
12. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
Beck SD; Patel MI; Sheinfeld J
J Urol; 2004 Jan; 171(1):168-71. PubMed ID: 14665869
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
14. Quantitative enzymatic hydrolysis of tRNAs: reversed-phase high-performance liquid chromatography of tRNA nucleosides.
Gehrke CW; Kuo KC; McCune RA; Gerhardt KO; Agris PF
J Chromatogr; 1982 Jul; 230(2):297-308. PubMed ID: 7050138
[TBL] [Abstract][Full Text] [Related]
15. Codon recognition by artificial tRNA molecules with modified nucleosides in the anticodon.
Satoh A; Takai K; Yokoyama S; Takaku H
Nucleic Acids Symp Ser; 1997; (37):117-8. PubMed ID: 9586027
[TBL] [Abstract][Full Text] [Related]
16. Analysis, identification and determination of urinary modified nucleosides of cancer and AIDS patients.
Nakano K; Yasaka T; Nakao T; Schram KH; Hammargren WM
Nucleic Acids Symp Ser; 1990; (22):31-2. PubMed ID: 2101906
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancer.
Bullinger D; Fröhlich H; Klaus F; Neubauer H; Frickenschmidt A; Henneges C; Zell A; Laufer S; Gleiter CH; Liebich H; Kammerer B
Anal Chim Acta; 2008 Jun; 618(1):29-34. PubMed ID: 18501242
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of RNA containing O-beta-D-ribofuranosyl-(1''-2')-adenosine-5''-phosphate and 1-methyladenosine, minor components of tRNA.
Mikhailov SN; Efimtseva EV; Rodionov AA; Shelkunova AA; Rozenski J; Emmerechts G; Schepers G; Van Aerschot A; Herdewijn P
Chem Biodivers; 2005 Sep; 2(9):1153-63. PubMed ID: 17193197
[TBL] [Abstract][Full Text] [Related]
19. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE.
Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H
Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143
[TBL] [Abstract][Full Text] [Related]
20. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
